<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bloody peritoneal dialysate (hemoperitoneum)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bloody peritoneal dialysate (hemoperitoneum)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bloody peritoneal dialysate (hemoperitoneum)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anthony Bleyer, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Megha Salani, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas A Golper, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Bloody peritoneal dialysate (hemoperitoneum) in the peritoneal dialysis patient is a common occurrence. The etiology, diagnosis, and treatment of this problem will be reviewed here. Other abdominal disorders in dialysis patients, including abnormalities requiring immediate surgical therapy, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1897.html" rel="external">"Unique aspects of gastrointestinal disease in patients on dialysis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ETIOLOGY AND EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The incidence of hemoperitoneum in patients on peritoneal dialysis varies from 6 percent overall to as high as 57 percent in premenopausal women [<a href="#rid1">1,2</a>]. Bloody peritoneal dialysate may be related to the peritoneal dialysis catheter, the peritoneal dialysis procedure, underlying kidney disease (such as polycystic kidney disease or acquired cystic changes), or factors unrelated to kidney disease  (<a class="graphic graphic_table graphicRef132671" href="/z/d/graphic/132671.html" rel="external">table 1</a>). Performance of peritoneal dialysis exchanges allows for earlier detection of intra-abdominal bleeding, including mild bleeding that might otherwise be clinically silent.</p><p>Causes of hemoperitoneum were reviewed in a single-center series of 424 patients; 26 patients (6 percent) developed one or more episodes of hemoperitoneum [<a href="#rid1">1</a>]. Based upon severity and cause of bleeding, patients could be divided into different groups:</p><p class="bulletIndent1"><span class="glyph">●</span>In the largest group (n = 21) of cases, bleeding was mild, asymptomatic, and resulted in pinkish or red discoloration of the fluid. These patients were treated conservatively and did not receive extensive evaluation. Menstrual bleeding was believed responsible in seven cases, while a bleeding diathesis (use of <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> or thrombocytopenia) was responsible in four patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peritoneal bleeding after transplant nephrectomy, increased physical activity, catheter repositioning, and femoral hematoma were responsible for single cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Minor bleeding with significant pathology was found in single patients with pancreatitis, sclerosing peritonitis, and postcolonoscopy, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe bleeding requiring intervention was observed in six patients, three with likely ovarian cyst rupture, one post-splenectomy, one post-catheter placement, and one with sclerosing peritonitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The cause was uncertain in six patients.</p><p></p><p>Some patients can have recurrent hemoperitoneum. In an observational study of 21 patients with recurrent hemoperitoneum, two-thirds of the patients were female [<a href="#rid3">3</a>]. Among the females, the most common cause was retrograde menstruation. Most cases among males were idiopathic. One-third of the patients in the entire cohort were taking <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> or therapeutic doses of <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a>. </p><p class="headingAnchor" id="H3"><span class="h2">Menstrual bleeding</span><span class="headingEndMark"> — </span>Benign hemoperitoneum occurs in over one-half of menstruating women on peritoneal dialysis; this is likely caused by ovulation, retrograde menstruation, or endometriosis [<a href="#rid2">2-4</a>]. In one study of 27 reproductive-age women undergoing continuous ambulatory peritoneal dialysis (CAPD) for more than three months, four of seven who menstruated developed hemoperitoneum [<a href="#rid2">2</a>]. Of 37 episodes of hemoperitoneum, 22 and 15 occurred at midcycle and with menstruation, respectively.</p><p>Such intra-abdominal bleeding would rarely be observed if peritoneal dialysis was not being performed. It is important to note that a very small amount of blood (&lt;1 mL) is enough to make 2 liters of peritoneal dialysate appear blood-tinged.</p><p>When such episodes occur, the woman should be reassured that the hemoperitoneum is benign and that it will likely resolve spontaneously. Rapid flushes (instillation of 500 mL to 1 L of dialysate allowed to dwell over one hour) and instillation of heparin (typically 500 units/L of instilled volume) in the dialysate to prevent catheter clotting are usually done. Infusing cool dialysate (ie, room temperature) may also be helpful [<a href="#rid5">5</a>]. Most commonly, the hemoperitoneum will clear after one to three rapid flushes. (See <a class="local">'Treatment'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Catheter-related</span><span class="headingEndMark"> — </span>After insertion of the peritoneal catheter, bleeding into the peritoneal cavity occurs in &lt;5 percent of cases [<a href="#rid1">1,2</a>]. Such bleeding is usually mild and resolves with the performance of several exchanges. (See  <a class="medical medical_review" href="/z/d/html/1885.html" rel="external">"Placement of the peritoneal dialysis catheter"</a>.)</p><p>Rarely, the peritoneal dialysis catheter may cause enough blunt trauma to result in a local laceration. There is one case report of a peritoneal catheter eroding into a mesenteric artery [<a href="#rid6">6</a>]. There have also been several reports of splenic lacerations resulting in massive hemoperitoneum [<a href="#rid7">7,8</a>]. Catheter-related hemoperitoneum is less common with the use of "coiled tip (intra-abdominal segment)" rather than "straight tip (intra-abdominal segment)" peritoneal dialysis catheters. More commonly, but still rarely, the peritoneal dialysis catheter may cause a mild contusion of the surface of the peritoneal cavity, resulting in some bleeding.</p><p class="headingAnchor" id="H2080239422"><span class="h2">Intra-abdominal pathology</span><span class="headingEndMark"> — </span>Hemoperitoneum may also develop as the result of intra-abdominal pathology similar to that which occurs in nondialysis patients. Potential causes include:</p><p class="bulletIndent1"><span class="glyph">●</span>Splenic rupture and infarct [<a href="#rid9">9,10</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Carcinomatosis of the liver or peritoneal metastases from metastatic cancer [<a href="#rid11">11</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Liver rupture and liver cyst rupture [<a href="#rid10">10</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Retroperitoneal hematoma [<a href="#rid12">12</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Iliopsoas hematoma [<a href="#rid13">13</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Intrauterine or ectopic pregnancy [<a href="#rid14">14</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhagic luteal cyst or ovarian cyst rupture [<a href="#rid15">15</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Spontaneous rectal sheath hematoma [<a href="#rid16">16</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Post-cardiac catheterization from a retroperitoneal hematoma [<a href="#rid17">17</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Intra-abdominal organ injury or vascular laceration due to cardiopulmonary resuscitation [<a href="#rid18">18,19</a>] </p><p class="bulletIndent1"><span class="glyph">●</span>Aneurysm rupture or other vascular catastrophe [<a href="#rid10">10</a>]</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Retroperitoneal pathology</span><span class="headingEndMark"> — </span>Hemoperitoneum may be the result of pathology in the retroperitoneum, often involving the kidney. Cyst rupture in patients with autosomal dominant polycystic kidney disease, acquired cystic disease [<a href="#rid20">20</a>], and kidney tumors are potential causes of bloody dialysate [<a href="#rid21">21,22</a>]. These patients may also have hematuria. Although very rare, and in this case unrelated to the peritoneal dialysis catheter, hemoperitoneum was reported in a peritoneal dialysis patient as a result of a leaking and subsequently ruptured aortic aneurysm [<a href="#rid23">23</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1680.html" rel="external">"Autosomal dominant polycystic kidney disease (ADPKD): Kidney manifestations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1683.html" rel="external">"Acquired cystic disease of the kidney in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2983.html" rel="external">"Clinical manifestations, evaluation, and staging of renal cell carcinoma"</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Additional causes</span><span class="headingEndMark"> — </span>Encapsulating peritoneal sclerosis (EPS) is an important and ominous cause of hemoperitoneum. It generally occurs in patients who have been on peritoneal dialysis for longer than one year; the risk for EPS increases with time on peritoneal dialysis. Bleeding in EPS is usually due to peritoneal inflammation and may be an early indicator of this condition [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/114179.html" rel="external">"Encapsulating peritoneal sclerosis in patients on peritoneal dialysis", section on 'Clinical features'</a>.)</p><p>Peritoneal calcification has also been associated with bloody peritoneal dialysate [<a href="#rid25">25</a>] (see  <a class="medical medical_review" href="/z/d/html/1973.html" rel="external">"Inadequate solute clearance in peritoneal dialysis"</a>). </p><p>Other conditions associated with bloody peritoneal dialysate include thrombocytopenia or coagulopathy [<a href="#rid1">1</a>], scurvy [<a href="#rid26">26</a>], post-colonoscopy state [<a href="#rid10">10,27</a>], peritonitis [<a href="#rid28">28</a>], or if peritoneal dialysis is resumed after a prolonged break. </p><p class="headingAnchor" id="H8"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>In peritoneal dialysis patients presenting with bloody peritoneal dialysate (hemoperitoneum), the goal of evaluation is to identify the underlying cause of bleeding in order to direct therapy. As an initial step, the clinician must distinguish patients who require urgent and rapid assessment for an acute intra-abdominal process in an emergency department from those who can be evaluated less urgently in the outpatient setting. However, in many cases, a cause for the bleeding cannot be established in spite of extensive evaluation.</p><p class="headingAnchor" id="H839818255"><span class="h2">Assessment for alarm findings</span><span class="headingEndMark"> — </span>In peritoneal dialysis patients who present with bloody peritoneal dialysate (hemoperitoneum), we begin with a careful history and physical examination to determine if the patient has any clinical features ("alarm findings") that suggest more significant intra-abdominal pathology  (<a class="graphic graphic_algorithm graphicRef120421" href="/z/d/graphic/120421.html" rel="external">algorithm 1</a>). Although such causes of hemoperitoneum are generally infrequent, they may be life-threatening and, therefore, require prompt recognition and management. (See <a class="local">'Patients with alarm findings'</a> below.)</p><p>Alarm findings include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding that is heavy (ie, causes peritoneal dialysate to no longer be translucent), persistent (ie, occurs with two or more exchanges), or recurrent</p><p class="bulletIndent1"><span class="glyph">●</span>Severe, unexplained abdominal pain</p><p class="bulletIndent1"><span class="glyph">●</span>Fever</p><p class="bulletIndent1"><span class="glyph">●</span>Hypotension</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal tenderness, distension, guarding, or rebound tenderness</p><p class="bulletIndent1"><span class="glyph">●</span>History of abdominal trauma of any kind within the past week</p><p class="bulletIndent1"><span class="glyph">●</span>History of abdominal procedure, such as colonoscopy [<a href="#rid10">10,29</a>], within the past month</p><p></p><p class="headingAnchor" id="H1157803401"><span class="h2">Patients with alarm findings</span><span class="headingEndMark"> — </span>Patients with hemoperitoneum and alarm findings (see <a class="local">'Assessment for alarm findings'</a> above) require urgent evaluation to exclude an underlying intra-abdominal process, such as cyst rupture or a vascular catastrophe (see <a class="local">'Intra-abdominal pathology'</a> above). Such patients should be immediately referred to the emergency department for further assessment and management, which should include the following  (<a class="graphic graphic_algorithm graphicRef120421" href="/z/d/graphic/120421.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Computed tomography (CT) scan of the abdomen and pelvis. If the patient's vital signs are stable, the CT scan should be obtained after the patient has been instructed to wear a drain bag and to change positions periodically for at least one hour to ensure that all peritoneal dialysate fluid has been drained (ie, dry abdomen). However, if the patient is hemodynamically unstable, the CT scan should be performed immediately without delay. Among patients with residual kidney function, the clinician should weigh the potential risks and benefits of intravenous (IV) contrast administration. (See  <a class="medical medical_review" href="/z/d/html/113083.html" rel="external">"Patient evaluation prior to oral or iodinated intravenous contrast for computed tomography", section on 'Patients receiving dialysis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peritoneal fluid spun hematocrit (&gt;2 percent suggests significant intraperitoneal pathology)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peritoneal fluid cell count and differential</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peritoneal fluid amylase (&gt;50 units/L is suggestive of an intra-abdominal process such as perforated ulcer, gall bladder or biliary tract disease, or ischemic bowel).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral blood complete blood count (CBC)</p><p></p><p>Based upon this evaluation, our subsequent approach is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with imaging findings consistent with an acute intra-abdominal process that could potentially require surgical intervention, patients with a peritoneal fluid amylase &gt;50 units/L, <strong>or </strong>patients with a decrease in hemoglobin of &gt;2 g/dL, we obtain a surgical consultation. Although not all of these patients will require an intervention, their presenting clinical findings are concerning enough to warrant a surgical evaluation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with peritoneal fluid findings consistent with peritonitis, we admit the patient for close monitoring and treat as appropriate with antibiotics. We reassess the patient upon completion of antibiotic therapy.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/1869.html" rel="external">"Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/1882.html" rel="external">"Microbiology and therapy of peritonitis in peritoneal dialysis", section on 'Antimicrobial therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients who do <strong>not </strong>have an identifiable potential cause for hemoperitoneum based upon imaging and laboratory findings, a surgical consultation for diagnostic laparoscopy is a reasonable option. If no surgical intervention is needed at the time of the initial evaluation, we advise inpatient admission and observation for at least 24 hours.</p><p></p><p>Patients whose primary alarm findings are severe abdominal pain, fever, or hypotension may require additional evaluation for these presenting symptoms, as discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/290.html" rel="external">"Evaluation of the adult with nontraumatic abdominal or flank pain in the emergency department"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">"Evaluation and management of suspected sepsis and septic shock in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/98976.html" rel="external">"Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock"</a>.)</p><p></p><p class="headingAnchor" id="H3470464148"><span class="h2">Patients without alarm findings</span><span class="headingEndMark"> — </span>In patients with hemoperitoneum who do <strong>not </strong>have alarm findings (see <a class="local">'Assessment for alarm findings'</a> above), the cause of hemoperitoneum is usually benign. Patients without alarm findings can generally be evaluated in the outpatient setting.</p><p>Our diagnostic approach is as follows  (<a class="graphic graphic_algorithm graphicRef120421" href="/z/d/graphic/120421.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>If the patient is a premenopausal woman who is experiencing menstrual bleeding or is in the middle of her menstrual cycle (ie, during ovulation), we attribute the cause of bleeding to retrograde menstruation or ovulation, respectively (see <a class="local">'Menstrual bleeding'</a> above). We provide reassurance that the hemoperitoneum is most likely benign, treat with supportive measures (see <a class="local">'Treatment'</a> below), and reassess the patient upon completion of menses or, if the patient is midcycle, ovulation. If bleeding resolves, we resume routine care and monitoring with no additional testing. If bleeding remains persistent, the patient should be evaluated for other possible causes of hemoperitoneum, as discussed below.</p><p></p><p class="bulletIndent1">For the woman who has bleeding associated with ovulation or menstruation, it is important to note that ovulation frequently stops as the patient begins dialysis; thus, continued menstrual bleeding after several months on dialysis may be the result of an ovarian cyst or tumor. Imaging of the ovaries and gynecologic consultation are appropriate in this setting.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the patient is <strong>not</strong> experiencing menstrual bleeding and is not midcycle, we perform the following evaluation:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We examine the peritoneal dialysis catheter and exit-site for bleeding or other drainage. In patients with a history of recent peritoneal catheter insertion or manipulation, we generally attribute the hemoperitoneum to mild, blunt, catheter-related trauma and administer supportive measures. (See <a class="local">'Treatment'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We obtain a peritoneal fluid cell count and differential and culture to rule out a diagnosis of peritonitis. If the peritoneal fluid findings are consistent with peritonitis, we treat as appropriate with antimicrobial agents, administer supportive measures for hemoperitoneum (see <a class="local">'Treatment'</a> below), and reassess the patient after completion of therapy. In general, hemoperitoneum is not a common presenting symptom of peritonitis in patients on peritoneal dialysis but has been anecdotally reported.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/1869.html" rel="external">"Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis", section on 'Peritoneal fluid analysis'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/1882.html" rel="external">"Microbiology and therapy of peritonitis in peritoneal dialysis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients who do not have any identifiable causes of hemoperitoneum based upon history, physical examination, and laboratory testing, we treat with supportive measures (see <a class="local">'Treatment'</a> below) and monitor the patient for recurrent bleeding.</p><p></p><p>If bleeding resolves with supportive measures, we resume routine care and monitoring. If the patient has recurrent bleeding, we obtain a CT scan of the abdomen and pelvis to evaluate for an underlying intra-abdominal process. CT of the abdomen and pelvis should be performed after the patient has been instructed to wear a drain bag and to change positions periodically for at least one hour to ensure that all peritoneal dialysate fluid has been drained (ie, dry abdomen). Among patients with residual kidney function, the clinician should weigh the potential risks and benefits of IV contrast administration. Further evaluation and management of the patient is guided by the imaging findings on CT. If the CT does not identify any cause for hemoperitoneum, we obtain a surgical consultation for possible diagnostic laparoscopy or laparotomy. (See  <a class="medical medical_review" href="/z/d/html/113083.html" rel="external">"Patient evaluation prior to oral or iodinated intravenous contrast for computed tomography"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>In peritoneal dialysis patients with bloody peritoneal dialysate (hemoperitoneum), treatment depends upon the underlying cause of hemoperitoneum. In most cases, bleeding is mild to moderate and resolves spontaneously, and supportive measures are usually sufficient to control the bleeding. Patients with heavy bleeding from an intra-abdominal process may require surgical intervention to stop the hemorrhage.</p><p>Regardless of the cause of hemoperitoneum, we suggest the following approach to management:</p><p class="bulletIndent1"><span class="glyph">●</span>In patients whose dialysate appears pink or blood tinged, we provide reassurance to the patient and advise the patient to resume routine dialysis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients whose dialysate appears frankly bloody, we perform the following supportive measures:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We instill heparin (500 units/L) in the dialysate to prevent clotting in the peritoneal catheter. Heparin is not systemically absorbed by the peritoneum and does not increase the risk of bleeding.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We advise the patient to perform two or three rapid exchanges with room-temperature dialysate to cause peritoneal vasoconstriction and decrease bleeding [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients taking <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>, antiplatelet agents, or anticoagulants, discontinuation of the agent(s) should be balanced against the therapeutic indications in the individual patient.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In women who are menstruating, we offer the option of oral contraceptives, which may prevent ovulation and control bleeding [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/117110.html" rel="external">"Pregnancy in patients on dialysis", section on 'Contraception'</a>.)</p><p></p><p class="headingAnchor" id="H41419698"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>In most patients, bloody peritoneal dialysate is related to menstrual bleeding. If bleeding is mild and results in blood-tinged dialysate, it usually resolves on its own and is associated with a good prognosis. In patients with more severe bleeding, the prognosis depends upon the underlying cause of the bloody dialysate. Although data are limited, one study of patients on continuous ambulatory peritoneal dialysis (CAPD) found that recurrent hemoperitoneum was not associated with any long-term effects on patient survival, predisposition to peritonitis, or ultrafiltration failure [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H3567972450"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112932.html" rel="external">"Society guideline links: Dialysis"</a>.)</p><p class="headingAnchor" id="H24440672"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – The incidence of bloody peritoneal dialysate (hemoperitoneum) in the peritoneal dialysis patient varies from 6 percent overall to as high as 57 percent in premenopausal women. (See <a class="local">'Etiology and epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Ovulation, retrograde menstruation, and endometriosis are common, benign causes of hemoperitoneum among menstruating women. Such bleeding generally resolves spontaneously. Other causes of hemoperitoneum include catheter-related problems (eg, lacerations or contusions), intra-abdominal pathology (eg, splenic rupture and infarct, carcinomatosis of the liver, liver cyst rupture), retroperitoneal pathology (eg, cyst rupture or kidney tumors), and encapsulating peritoneal sclerosis (EPS)  (<a class="graphic graphic_table graphicRef132671" href="/z/d/graphic/132671.html" rel="external">table 1</a>). (See <a class="local">'Etiology and epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment for alarm findings</strong> – In peritoneal dialysis patients who present with bloody peritoneal dialysate, we begin with a careful history and physical examination to determine if the patient has any clinical features ("alarm findings") that suggest more significant intra-abdominal pathology  (<a class="graphic graphic_algorithm graphicRef120421" href="/z/d/graphic/120421.html" rel="external">algorithm 1</a>). Although such causes of hemoperitoneum are generally infrequent, they may be life threatening and therefore require prompt recognition and management. Alarm findings include the following (See <a class="local">'Assessment for alarm findings'</a> above.):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding that is heavy (ie, causes peritoneal dialysate to no longer be translucent), persistent (ie, occurs with two or more exchanges), or recurrent</p><p class="bulletIndent2"><span class="glyph">•</span>Severe, unexplained abdominal pain</p><p class="bulletIndent2"><span class="glyph">•</span>Fever</p><p class="bulletIndent2"><span class="glyph">•</span>Hypotension</p><p class="bulletIndent2"><span class="glyph">•</span>Abdominal tenderness, distension, guarding, or rebound tenderness</p><p class="bulletIndent2"><span class="glyph">•</span>History of recent abdominal trauma of any kind</p><p class="bulletIndent2"><span class="glyph">•</span>History of recent abdominal procedure, such as colonoscopy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with alarm findings</strong> – Patients with hemoperitoneum and alarm findings require urgent evaluation to exclude an underlying intra-abdominal process, such as cyst rupture or a vascular catastrophe. Such patients should be immediately referred to the emergency department for further assessment and management. (See <a class="local">'Patients with alarm findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients without alarm findings </strong>– In patients with hemoperitoneum who do <strong>not </strong>have alarm findings, the cause of hemoperitoneum is usually benign. Patients without alarm findings can generally be evaluated in the outpatient setting. (See <a class="local">'Patients without alarm findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Treatment depends upon the underlying cause of hemoperitoneum. In most cases, bleeding is mild to moderate and resolves spontaneously, and supportive measures are usually sufficient to control the bleeding. Patients with heavy bleeding from an intra-abdominal process may require surgical intervention to stop the hemorrhage. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="headingAnchor" id="H464015636"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges John Burkart, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Greenberg A, Bernardini J, Piraino BM, et al. Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review. Am J Kidney Dis 1992; 19:252.</a></li><li><a class="nounderline abstract_t">Harnett JD, Gill D, Corbett L, et al. Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis. Ann Intern Med 1987; 107:341.</a></li><li><a class="nounderline abstract_t">Tse KC, Yip PS, Lam MF, et al. Recurrent hemoperitoneum complicating continuous ambulatory peritoneal dialysis. Perit Dial Int 2002; 22:488.</a></li><li><a class="nounderline abstract_t">Dimitriadis CA, Bargman JM. Gynecologic issues in peritoneal dialysis. Adv Perit Dial 2011; 27:101.</a></li><li><a class="nounderline abstract_t">Goodkin DA, Benning MG. An outpatient maneuver to treat bloody effluent during continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10:227.</a></li><li><a class="nounderline abstract_t">Miller R, Denman R, Saltissi D, et al. Erosion of a mesenteric vessel by a Tenckhoff catheter. Perit Dial Int 1996; 16:528.</a></li><li><a class="nounderline abstract_t">Van der Niepen P, Sennesael JJ, Verbeelen DL. Massive hemoperitoneum due to spleen injury by a dislocated Tenckhoff catheter. Perit Dial Int 1994; 14:90.</a></li><li><a class="nounderline abstract_t">de los Santos CA, von Eye O, d'Avila D, Mottin CC. Rupture of the spleen: a complication of continuous ambulatory peritoneal dialysis. Perit Dial Int 1986; 6:203.</a></li><li><a class="nounderline abstract_t">Syed A, Holley JL, Piraino B. Splenic infarct presenting as sterile peritonitis with peripheral embolic phenomena. Adv Perit Dial 1993; 9:202.</a></li><li><a class="nounderline abstract_t">Lew SQ. Hemoperitoneum: bloody peritoneal dialysate in ESRD patients receiving peritoneal dialysis. Perit Dial Int 2007; 27:226.</a></li><li><a class="nounderline abstract_t">Fine A, Novak C. Hemoperitoneum due to carcinomatosis in the liver of a CAPD patient. Perit Dial Int 1996; 16:181.</a></li><li><a class="nounderline abstract_t">Fernández Girón F, Hermosilla Sánchez F, Parallé Alcalde M, González Martínez J. Hemoperitoneum in peritoneal dialysis secondary to retroperitoneal hematoma. Perit Dial Int 1996; 16:644.</a></li><li><a class="nounderline abstract_t">Campisi S, Cavatorta F, De Lucia E. Iliopsoas spontaneous hematoma: an unusual cause of hemoperitoneum in CAPD patients. Perit Dial Int 1992; 12:78.</a></li><li><a class="nounderline abstract_t">Lew SQ. Persistent hemoperitoneum in a pregnant patient receiving peritoneal dialysis. Perit Dial Int 2006; 26:108.</a></li><li><a class="nounderline abstract_t">Kohn OF, Culbertson S, Becker YT. Hemoperitoneum in a Peritoneal Dialysis Patient: Ruptured Ectopic Pregnancy. Perit Dial Int 2018; 38:455.</a></li><li><a class="nounderline abstract_t">Balafa O, Koundouris S, Mitsis M, Siamopoulos KC. An unusual case of hemoperitoneum: spontaneous rectus sheath hematoma. Perit Dial Int 2014; 34:134.</a></li><li><a class="nounderline abstract_t">Balsera C, Guest S. Hemoperitoneum in a peritoneal dialysis patient from a retroperitoneal source. Adv Perit Dial 2013; 29:69.</a></li><li><a class="nounderline abstract_t">Goel N, Haddad DB, Jain D. Hemoperitoneum After Cardiopulmonary Resuscitation in Peritoneal Dialysis Patients: A Tale of Two Cases. Int J Nephrol Renovasc Dis 2020; 13:379.</a></li><li><a class="nounderline abstract_t">Koutserimpas C, Ioannidis A, Siaperas P, et al. Intra-Abdominal Hemorrhage following Cardiopulmonary Resuscitation: A Report of Two Cases. Case Rep Emerg Med 2018; 2018:5243105.</a></li><li><a class="nounderline abstract_t">Borràs M, Valdivielso JM, Egido R, et al. Haemoperitoneum caused by bilateral renal cyst rupture in an ACKD peritoneal dialysis patient. Nephrol Dial Transplant 2006; 21:789.</a></li><li><a class="nounderline abstract_t">Rinaldi S, Sera F, Verrina E, et al. The Italian Registry of Pediatric Chronic Peritoneal Dialysis: a ten-year experience with chronic peritoneal dialysis catheters. Perit Dial Int 1998; 18:71.</a></li><li><a class="nounderline abstract_t">García Falcón T, Rodríguez-Carmona A, Pérez Fontán M, et al. Complications of permanent catheter implantation for peritoneal dialysis: incidence and risk factors. Adv Perit Dial 1994; 10:206.</a></li><li><a class="nounderline abstract_t">Yap DY, Yip TP, Lui SL, Lo WK. Ruptured abdominal aortic aneurysm as a cause of spontaneous hemoperitoneum in a patient on peritoneal dialysis. Perit Dial Int 2011; 31:600.</a></li><li><a class="nounderline abstract_t">Pollock CA. Bloody ascites in a patient after transfer from peritoneal dialysis to hemodialysis. Semin Dial 2003; 16:406.</a></li><li><a class="nounderline abstract_t">Warady BA, Bohl V, Alon U, Hellerstein S. Symptomatic peritoneal calcification in a child: Treatment with tidal peritoneal dialysis. Perit Dial Int 1994; 14:4.</a></li><li><a class="nounderline abstract_t">Kittisakmontri K, Swangtrakul N, Padungmaneesub W, Charoenkwan P. Gingival Bleeding and Bloody Dialysate: A Case Report of Scurvy in a Child With End-Stage Renal Disease Receiving Peritoneal Dialysis. J Ren Nutr 2016; 26:407.</a></li><li><a class="nounderline abstract_t">Luni FK, Bawany MZ, Khan AR, et al. Haemoperitoneum post colonoscopy in a continuous ambulatory peritoneal dialysis patient. Arab J Gastroenterol 2014; 15:159.</a></li><li class="breakAll">Vas SI. Peritonitis. In: Peritoneal Dialysis, 3rd ed., Nolph KD (Ed), Kluwer Academic Publishers, Boston 1989. p.261.</li><li><a class="nounderline abstract_t">Walshe JJ, Lee JB, Gerbasi JR. Continuous ambulatory peritoneal dialysis complicated by massive hemoperitoneum after colonoscopy. Gastrointest Endosc 1987; 33:468.</a></li></ol></div><div id="topicVersionRevision">Topic 1923 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1553970" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3619223" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12322820" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Recurrent hemoperitoneum complicating continuous ambulatory peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22073839" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Gynecologic issues in peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2094462" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : An outpatient maneuver to treat bloody effluent during continuous ambulatory peritoneal dialysis (CAPD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8914183" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Erosion of a mesenteric vessel by a Tenckhoff catheter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8312427" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Massive hemoperitoneum due to spleen injury by a dislocated Tenckhoff catheter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Rupture of the spleen: a complication of continuous ambulatory peritoneal dialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8105924" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Splenic infarct presenting as sterile peritonitis with peripheral embolic phenomena.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17468466" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hemoperitoneum: bloody peritoneal dialysate in ESRD patients receiving peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9147556" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hemoperitoneum due to carcinomatosis in the liver of a CAPD patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8981538" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Hemoperitoneum in peritoneal dialysis secondary to retroperitoneal hematoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1543788" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Iliopsoas spontaneous hematoma: an unusual cause of hemoperitoneum in CAPD patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16538884" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Persistent hemoperitoneum in a pregnant patient receiving peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30413637" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Hemoperitoneum in a Peritoneal Dialysis Patient: Ruptured Ectopic Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24525605" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : An unusual case of hemoperitoneum: spontaneous rectus sheath hematoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24344496" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Hemoperitoneum in a peritoneal dialysis patient from a retroperitoneal source.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33364811" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hemoperitoneum After Cardiopulmonary Resuscitation in Peritoneal Dialysis Patients: A Tale of Two Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29974000" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intra-Abdominal Hemorrhage following Cardiopulmonary Resuscitation: A Report of Two Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16368703" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Haemoperitoneum caused by bilateral renal cyst rupture in an ACKD peritoneal dialysis patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9527033" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The Italian Registry of Pediatric Chronic Peritoneal Dialysis: a ten-year experience with chronic peritoneal dialysis catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7999829" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Complications of permanent catheter implantation for peritoneal dialysis: incidence and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21976477" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Ruptured abdominal aortic aneurysm as a cause of spontaneous hemoperitoneum in a patient on peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12969397" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Bloody ascites in a patient after transfer from peritoneal dialysis to hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Symptomatic peritoneal calcification in a child: Treatment with tidal peritoneal dialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27118080" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Gingival Bleeding and Bloody Dialysate: A Case Report of Scurvy in a Child With End-Stage Renal Disease Receiving Peritoneal Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25483306" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Haemoperitoneum post colonoscopy in a continuous ambulatory peritoneal dialysis patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25483306" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Haemoperitoneum post colonoscopy in a continuous ambulatory peritoneal dialysis patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3443277" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Continuous ambulatory peritoneal dialysis complicated by massive hemoperitoneum after colonoscopy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
